[1] SCHNEIDER B J,NAIDOO J,SANTOMASSO B D,et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy:ASCO Guideline Update[J]. J Clin Oncol,2021,39(36):4073-4126.
[2] IKUSHIMA S,ONO R,FUKUDA K,et al. Trousseau′s syndrome:cancer-associated thrombosis[J]. Jpn J Clin Oncol,2016,46(3):204-208.
[3] KHORANA A A. Venous thromboembolism and prognosis in cancer[J]. Thromb Res,2010,125(6):490-493.
[4] DUNBAR A,BOLTON K L,DEVLIN S M,et al. Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors[J]. Blood,2021,137(15):2103-2113.
[5] JI J,XUE T F,GUO X D,et al. Antagonizing peroxisome proliferator-activated receptor γ facilitates M1-to-M2 shift of microglia by enhancing autophagy via the LKB1-AMPK signaling pathway[J]. Aging Cell,2018,17(4):e12774.
[6] DEMERS M,WONG S L,MARTINOD K,et al. Priming of neutrophils toward NETosis promotes tumor growth[J]. Oncoimmunology,2016,5(5):e1134073.
[7] SATO R,IMAMURA K,SAKATA S,et al. Disorder of coagulation-fibrinolysis system:an emerging toxicity of anti-PD-1/PD-L1 monoclonal antibodies[J]. J Clin Med,2019,8(6) :762.
[8] HORIO Y,TAKAMATSU K,TAMANOI D,et al. Trousseau′s syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient[J]. Eur J Immunol,2018,48(10):1764-1767.
[9] SOGA Y,TAIRA K,SUGIMOTO A,et al. Mitral valve nonbacterial thrombotic endocarditis:a rare multi-surgery-tolerant survivor of Trousseau′s syndrome[J]. Surg Case Rep,2018,4(1):104.
[1]宋嘉 综述,付蓉 审校.免疫检查点抑制剂相关内分泌代谢疾病[J].天津医科大学学报,2021,27(04):427.